PorA Variable Regions of Neisseria meningitidis

Emerging Infectious Diseases

Volumn 10, Issue 4, 2004, Pages 674-678

  Russell, Joanne E ^a,b   Jolley, Keith A ^a   Feavers, Ian M ^b   Maiden, Martin C J ^a   Suker, Janet ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; PORIN A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; GENE AMPLIFICATION; IMMUNOGENICITY; NEISSERIA MENINGITIDIS; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PORA GENE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

EID: 1842484128     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1004.030247     Document Type: Article

References (17)

1. Pollard AJ, Maiden MCJ. Meningococcal disease. Totowa (NJ): Humana Press; 2001.
2. Kuipers B, van den Dobbelsteen G, Wedege E, van Alphen L. Serological characterization. In: Pollard AJ, Maiden MC, editors. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; 2001. p. 131-45.
3. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 1985;7:504-10.
4. Martin SL, Borrow R, van der Ley P, Dawson M, Fox AJ, Cartwright KAV. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine 2000;18:2476-81.
5. Jodar L, Feavers IM, Salisbury D, Granoff DM. Development of vaccines against meningococcal disease. Lancet 2002;359:1499-508.
6. Suker J, Feavers IM, Achtman M, Morelli G, Wang J-F, Maiden MCJ. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 1994;12:253-65.
7. Sacchi CT, Lemos APS, Brandt ME, Whitney AM, Melles CEA, Solari CA, et al. Proposed standardisation of Neisseria meningitidis PorA variable region typing nomenclature. Clin Diagn Lab Immunol 1998;5:845-55.
8. Maiden MCJ, Russell J, Suker J, Feavers IM. Neisseria meningitidis subtype nomenclature. Clin Diagn Lab Immunol 1999;6:771-2.
9. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998;95:3140-5.
10. Feavers IM, Maiden MCJ. A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol Microbiol 1998;30:647-56.
11. Embley TM. The linear PCR reaction: a simple and robust method for sequencing amplified rRNA genes. Lett Appl Microbiol 1991;13:171-4.
12. Staden R. The Staden sequence analysis package. Mol Biotechnol 1996;5:233-41.
13. Womble DD. GCG: the Wisconsin Package of sequence analysis programs. Methods Mol Biol 2000;132:3-22.
14. Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics 1998;14:68-73.
15. Russell J. Variation in the PorA protein and clonal diversity within the UK Neisseria meningitidis population over a twenty year period (1975-1995). [doctoral thesis]. Oxford: The Open University; 2001.
16. Takahata N, Kimura M. A model of evolutionary base substitutions and its application with special reference to rapid change of pseudogenes. Genetics 1981;98:641-57.
17. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402.